| Business Summary | | Omnicell,
Inc.,
formerly
Omnicell.com,
provides
an
integrated
suite
of
clinical
infrastructure
and
workflow
automation
solutions
for
healthcare
facilities.
These
solutions
include
pharmacy
and
supply
systems,
clinical
reference
tools,
an
Internet-based
procurement
application
and
decision
support
tools.
The
Company
sells
and
leases
its
products
and
related
services
to
a
wide
range
of
healthcare
facilities,
such
as
hospitals,
integrated
delivery
networks
and
specialty
care
facilities,
which
include
nursing
homes,
outpatient
surgery
centers,
catheterization
labs
and
clinics.
Omnicell's
clinical
infrastructure
and
workflow
automation
solutions
are
designed
to
reduce
medication
errors;
reduce
costs;
improve
operating
efficiency;
leverage
investments
in
existing
information
systems;
simplify
the
process
of
ordering
pharmaceuticals
and
medical
supplies,
and
monitor
utilization
trends.
As
of
March
31,
2001,
Omnicell
had
installed
over
18,600
pharmacy
and
supply
systems
in
the
United
States. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | OMCL
provides
a
comprehensive,
buyer-focused,
supply
chain
management
solution
that
addresses
the
limitations
of
traditional
healthcare
supply
chain.
For
the
three
months
ended
3/31/01,
revenues
rose
31%
to
$19
million.
Net
loss
fell
75%
to
$7.4
million.
Revenues
reflect
an
increase
in
the
number
of
pharmacy
and
supply
systems
installed
resulting
from
sales
and
shipment
activities.
Lower
loss
reflects
an
improved
gross
profit
margin
attributable
to
lower
costs
of
services. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000
Compensation | | Pay | Exer | |
| Randall Lipps, 44 Chairman | $453K | $21K | Sheldon Asher, 47 Pres,
CEO, Director | 453K | 666K | Robert Newell, IV, 53 CFO,
VP-Fin. | 203K | -- | John Higham, 59 VP
of Engineering , CTO | 296K | 46K | S. Michael Hanna, 50 VP
of Sales and Field Operations | 299K | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|